Despite longstanding recognition of thymic epithelial neoplasms, there is no official American Joint Committee on Cancer/ Union for International Cancer Control stage classification. This article summarizes proposals for classification of the T component of stage classification for use in the 8th edition of the tumor, node, metastasis classification for malignant tumors. This represents the output of the International Association for the Study of Lung Cancer and the International Thymic Malignancies Interest Group Staging and Prognostics Factor Committee, which assembled and analyzed a worldwide database of 10,808 patients with thymic malignancies from 105 sites. The committee proposes division of the T component into four categories, representing levels of invasion. T1 includes tumors localized to the thymus and anterior mediastinal fat, regardless of capsular invasion, up to and including infiltration through the mediastinal pleura. Invasion of the pericardium is designated as T2. T3 includes tumors with direct involvement of a group of mediastinal structures either singly or in combination: lung, brachiocephalic vein, superior vena cava, chest wall, and phrenic nerve. Invasion of more central structures constitutes T4: aorta and arch vessels, intrapericardial pulmonary artery, myocardium, trachea, and esophagus. Size did not emerge as a useful descriptor for stage classification. This classification of T categories, combined with a classification of N and M categories, provides a basis for a robust tumor, node, metastasis classification system for the 8th edition of American Joint Committee on Cancer/Union for International Cancer Control stage classification.

The IASLC/ITMIG thymic epithelial tumors staging project: Proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors / A.G. Nicholson, F.C. Detterbeck, M. Marino, J. Kim, K. Stratton, D. Giroux, H. Asamura, J. Crowley, C. Falkson, P.L. Filosso, G. Giaccone, J. Huang, K. Kondo, M. Lucchi, E.M. Marom, M. Okumura, E. Ruffini, P. Van Schil, P. Goldstraw, R. Rami-Porta, D. Ball, D. Beer, R. Beyruti, V. Bolejack, K. Chansky, W.E.E. Eberhardt, J. Edwards, F. Galateau-Salle, F. Gleeson, P. Groome, C. Kennedy, L. Kingsbury, Y.T. Kim, H. Kondo, M. Krasnik, K. Kubota, A. Lerut, G. Lyons, J. Van Meerbeeck, A. Mitchell, T. Nakano, A. Nowak, M. Peake, T. Rice, K. Rosenzweig, V. Rusch, N. Saijo, J.-. Sculier, L. Shemanski, K. Suzuki, Y. Tachimori, C.F. Thomas, W. Travis, M.S. Tsao, A. Turrisi, J. Vansteenkiste, H. Watanabe, Y.-. Wu, P. Baas, J. Erasmus, S. Hasegawa, K. Inai, K. Kernstine, H. Kindler, L. Krug, K. Nackaerts, H. Pass, D. Rice, E. Blackstone, S. Call Caja, U. Ahmad, F. Detterbeck, N. Girard, S.J. Haam, D.R. Gomez, M.K. Bae, P. Strobel, A. Marx, S. Saita, H. Wakelee, L. Bertolaccini, E. Vallieres, W. Scott, S. Su, B. Park, J. Marks, S. Khella, R. Shen, M. Rosenberg, V. Tomulescu, C. Foroulis, L. Lang-Lazdunski, A. Bille, J.G. Maessen, M. Keijzers, H. Van Veer, C. Wright, F. Facciolo, G. Palmieri, C. Buonerba, M. Ferguson, G. Marulli, P. Loehrer, M. Kalkat, K. Rohrberg, G. Daugaard, A. Toker, S. Erus, M. Kimmich, A. Brunelli, M. Refai, A. Nicholson, E. Lim, I.K. Park, J. Wagner, B. Tieu, W. Fang, J. Zhang, Z. Yu, Y. Han, Y. Li, K. Chen, G. Chen, K. Nagai, Y. Fujii, J. Nakajima, N. Ikeda, S. Haraguchi, T. Onuki, I. Yoshino, M. Tsuchida, S. Takahashi, K. Yokoi, M. Hanyuda, H. Niwa, H. Date, Y. Maniwa, S. Miyoshi, A. Iwasaki, T. Okamoto, T. Nagayasu, F. Tanaka, M. Suzuki, K. Yoshida, Y. Okuma, H. Horio, A. Matsumura, M. Higashiyama, H. Suehisa, T. Onuki, Y. Sano, K. Kondo, K. Al Kattan, R. Cerfolio, C. Gebitekin, D. Gomez De Antonio, K.H. Kernstine, N. Altorki, N. Novoa, M. Scarci, L. Voltolini, W. Weder, W. Zurek, A. Arame, C. Casadio, P. Carbognani, G. Donati, S. Keshavjee, W. Klepetko, B. Moser, C. Lequaglie, M. Liberman, M. Mancuso, M. Nosotti, L. Spaggiari, P.A. Thomas, E. Rendina, F. Venuta, M. Anile, J. Schutzner, G. Rocco. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - 9:9(2014), pp. S73-S80. [10.1097/JTO.0000000000000303]

The IASLC/ITMIG thymic epithelial tumors staging project: Proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors

M. Nosotti;L. Spaggiari;G. Rocco
2014

Abstract

Despite longstanding recognition of thymic epithelial neoplasms, there is no official American Joint Committee on Cancer/ Union for International Cancer Control stage classification. This article summarizes proposals for classification of the T component of stage classification for use in the 8th edition of the tumor, node, metastasis classification for malignant tumors. This represents the output of the International Association for the Study of Lung Cancer and the International Thymic Malignancies Interest Group Staging and Prognostics Factor Committee, which assembled and analyzed a worldwide database of 10,808 patients with thymic malignancies from 105 sites. The committee proposes division of the T component into four categories, representing levels of invasion. T1 includes tumors localized to the thymus and anterior mediastinal fat, regardless of capsular invasion, up to and including infiltration through the mediastinal pleura. Invasion of the pericardium is designated as T2. T3 includes tumors with direct involvement of a group of mediastinal structures either singly or in combination: lung, brachiocephalic vein, superior vena cava, chest wall, and phrenic nerve. Invasion of more central structures constitutes T4: aorta and arch vessels, intrapericardial pulmonary artery, myocardium, trachea, and esophagus. Size did not emerge as a useful descriptor for stage classification. This classification of T categories, combined with a classification of N and M categories, provides a basis for a robust tumor, node, metastasis classification system for the 8th edition of American Joint Committee on Cancer/Union for International Cancer Control stage classification.
Prognosis; Thymoma; Thymic carcinoma; Staging; Stage classification
Settore MED/21 - Chirurgia Toracica
2014
Article (author)
File in questo prodotto:
File Dimensione Formato  
J Thorac Oncol (The IASLC ITMIG... T components...).pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 565.39 kB
Formato Adobe PDF
565.39 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/707215
Citazioni
  • ???jsp.display-item.citation.pmc??? 55
  • Scopus 138
  • ???jsp.display-item.citation.isi??? 111
social impact